David Hough, MD

There is an unmet need in patients with depression and active suicidal ideation for new therapies that can rapidly bridge the gap until antidepressants take effect. Read this article...

Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).

High rates of schizophrenia symptom recurrence after antipsychotic treatment discontinuation are are thought to be due to withdrawal-related phenomena rather than illness recurrence. This post hoc analysis examines results...